Inhibrx Biosciences, Inc. INBX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s quick ratio?
- Inhibrx Biosciences, Inc. (INBX) reported quick ratio of 6.5× in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s quick ratio changed year-over-year?
- Inhibrx Biosciences, Inc.'s quick ratio increased by 26.3% year-over-year, from 5.1× to 6.5×.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s quick ratio?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s quick ratio has grown at a -13.4% compound annual growth rate (CAGR), from 5.2× to 3.9×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.